IRWDIronwood Pharmaceuticals, Inc.
3.950USD+0.77%Mkt Cap: 654.34M USDP/E: 6.41Last update: 2026-05-26

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linacl…

Indicators:|

Key Statistics

Company
Market Cap654.34M USD
Enterprise Value1.01B USD
Revenue (TTM)361.51M USD
Gross Profit271.87M USD
Net Income (TTM)24.02M USD
Revenue/Share2.225 USD
Last Price3.950 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees100
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS46333X1081
Valuation
P/E (Trailing)6.41
P/E (Forward)2.67
PEG
EV/EBITDA4.96
EV/Revenue2.80
P/S1.75
P/B-2.92
EPS (TTM)0.62
EPS (Forward)1.44
52W Range
0.550065% of range5.780
52W High5.780 USD
52W Low0.5500 USD
Profitability
Gross Margin75.20%
Oper. Margin68.10%
EBITDA Margin56.40%
Profit Margin8.11%
ROE-9.17%
ROA6.05%
Growth
Revenue Growth158.90%
Earnings Growth
Cash Flow & Leverage
Operating CF127.04M USD
CapEx (TTM)34.00K USD
FCF Margin14.15%
FCF Yield7.82%
Net Debt376.89M USD
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity-2.28
Current Ratio1.41
Quick Ratio1.38
Book Value/Sh-1.3190 USD
Cash/Share1.339 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1194:1000
Split DateApr 2, 2019
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)6.100 USD
Target Range3.700 USD10.00 USD
# Analysts4
Ownership
Shares Out.164.61M
Float136.34M
Insiders2.93%
Institutions98.11%
Short Interest
Short Ratio9.6d
Short % Float11.46%
Short % Out.10.49%
Shares Short17.27M
Short (prev mo.)17.90M
Technical
SMA 503.785 (+4.4%)
SMA 2003.035 (+30.1%)
Beta0.30
S&P 52W Chg28.31%
Avg Vol (30d)2.43M
Avg Vol (10d)2.69M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)